Search filters

List of works by Robert Toto

A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD

scientific article published on 07 December 2020

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

scientific article published on 30 October 2009

Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death

scientific article published on May 2010

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

scientific article

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

article

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

scientific article published in November 2013

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

scientific article published on 16 September 2016

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

scientific article

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

scientific article

Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings

scientific article published on 22 March 2012

Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials

scientific article published on 22 March 2012

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology

scientific article published on 22 March 2012

Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial

scientific article published on 3 November 2017

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

article

Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

article

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

article

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

scientific article published on 22 May 2015

Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).

scientific article

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

scientific article published on 28 February 2013

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

article

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

scientific article published on 19 December 2018

Paulina is supported by:

About Paulina

Help